Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a new build/version of the page's content rather than changes to the study data.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a new page build. This change does not modify any study data, eligibility criteria, or results.SummaryDifference0.1%

- Check38 days agoChange DetectedA publication citation under Study Publications was updated, changing how the same article is referenced (publication timing/formatting) from one citation variant to another.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a new publication citation to the Publications section (Dermatol Ther, 2026 Mar 16) and updated the page revision to v3.5.0 (from v3.4.3).SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.3 implemented, replacing v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.